[New Dutch practice guideline for administration of vitamin K to full-term newborns]

Area of Science:

• Neonatal Medicine
• Pediatric Hematology
• Nutritional Science

Context:

• Vitamin K deficiency bleeding (VKDB) poses a risk to newborns and infants, with early, classic, and late forms.
• Current Dutch guidelines involve initial oral vitamin K and a daily 25 μg dose from day 8.
• Existing prophylaxis is effective for healthy breastfed infants but insufficient for those with fat malabsorption, like in cholestasis.

Purpose:

• To evaluate the efficacy of current vitamin K prophylaxis against VKDB in newborns and infants.
• To determine the need for revised vitamin K dosage in breastfed infants, particularly those with impaired fat absorption.
• To update the Dutch practice guideline for vitamin K administration based on new evidence and recommendations.

Summary:

• Vitamin K deficiency bleeding (VKDB) can occur from hours to months after birth, with distinct early, classic, and late presentations.
• A daily dose increase of vitamin K from 25 μg to 150 μg for breastfed infants from day 8 to 12 weeks is implemented.
• This revised dosage aims to provide enhanced protection against VKDB, especially for breastfed infants experiencing fat malabsorption.

Impact:

• The updated guideline aims to significantly reduce the incidence of serious hemorrhage in vulnerable infants.
• Increased vitamin K dosage ensures better absorption and efficacy in breastfed infants with conditions affecting fat absorption.
• This proactive measure enhances infant health outcomes by preventing potentially life-threatening VKDB events.